ADVFN Logo
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

BHVN Biohaven Ltd

38.54
-0.18 (-0.46%)
After Hours
Last Updated: 16:07:24
Delayed by 15 minutes

Period:

Draw Mode:

Volume 1,850,359
Bid Price
Ask Price
News -
Day High 38.95

Low
12.35

52 Week Range

High
62.21

Day Low 36.77
Company Name Stock Ticker Symbol Market Type
Biohaven Ltd BHVN NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.18 -0.46% 38.54 16:07:24
Open Price Low Price High Price Close Price Prev Close
38.95 36.77 38.95 38.54 38.72
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
19,199 1,850,359 $ 38.19 $ 70,664,949 - 12.35 - 62.21
Last Trade Time Type Quantity Stock Price Currency
16:37:45 priorref 1,881 $ 38.54 USD

Biohaven (BHVN) Options Flow Summary

Overall Flow

Bearish

Net Premium

-477k

Calls / Puts

50.00%

Buys / Sells

50.00%

OTM / ITM

50.00%

Sweeps Ratio

0.00%

Biohaven Ltd Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
3.15B 81.58M - 0 -408.17M -5.00 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Biohaven News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No BHVN Message Board. Create One! See More Posts on BHVN Message Board See More Message Board Posts

Historical BHVN Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week42.9043.3136.7740.052,242,385-4.36-10.16%
1 Month57.0257.0236.7745.251,401,522-18.48-32.41%
3 Months44.9262.2136.7750.731,324,554-6.38-14.20%
6 Months27.4762.2125.9743.811,227,17111.0740.30%
1 Year13.5562.2112.3533.171,166,18824.99184.43%
3 Years74.63152.567.1064.861,039,698-36.09-48.36%
5 Years63.07152.567.1062.35920,574-24.53-38.89%

Biohaven Description

Biohaven Ltd is a clinical-stage biopharmaceutical company focused on discovering and developing therapies to improve the lives of patients with debilitating neurological and neuropsychiatric diseases, immunology, and disease-related biology, including rare disorders.

Your Recent History

Delayed Upgrade Clock